Neuropathic Pain Market : Table of Content


  • Published On : Jan-2020 |
  • Pages : 182 Pages |
  • Format : Neuropathic Pain Market Neuropathic Pain Market Neuropathic Pain Market Neuropathic Pain Market

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Dynamics

    3.1. Macro-Economic Factors

    3.2. Drivers

        3.2.1. Supply Side Drivers 

        3.2.2. Demand Side Drivers

    3.3. Restraints

    3.4. Opportunities

    3.5. Trends

4. Key Inclusions

    4.1. Clinical Trials

5. Global Neuropathic Pain Management Market Value Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class 

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 - 2029

        6.3.1. Tricyclic Anti-Depressants

        6.3.2. Anticonvulsants

        6.3.3. SNRI's

        6.3.4. Capsaicin Cream

        6.3.5. Local Anaesthesia

        6.3.6. Opioids

        6.3.7. Steroids

        6.3.8. Others

    6.4. Market Attractiveness Analysis By Drug Class 

7. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Indication 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2018

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 - 2029

        7.3.1. Diabetic Neuropathy

        7.3.2. Trigeminal Neuralgia

        7.3.3. Post-Herpetic Neuralgia

        7.3.4. Chemotherapy-Induced Peripheral Neuropathy

        7.3.5. Others

    7.4. Market Attractiveness Analysis By Indication 

8. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

    8.1.  Introduction / Key Findings

    8.2.  Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

    8.3.  Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029

        8.3.1. Retail Pharmacies

        8.3.2. Hospital Pharmacies

        8.3.3. Online Pharmacies

    8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    9.1.  Introduction

    9.2.  Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

    9.3.  Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa

    9.4.  Market Attractiveness Analysis By Region

10. North America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

    10.1.  Introduction

    10.2.   Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    10.3.  Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        10.3.1.  By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By Drug Class

        10.3.3. By Indication

        10.3.4. By Distribution Channel

    10.4. Market Attractiveness Analysis

    10.5. Key Impact Analysis

11. Latin America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        11.3.1.  By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Argentina

            11.3.1.4. Rest of Latin America

        11.3.2. By Drug Class

        11.3.3. By Indication

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis

    11.5. Key Impact Analysis

12. Europe Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

    12.1.  Introduction

    12.2.  Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    12.3.  Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        12.3.1.  By Country

            12.3.1.1. U.K.

            12.3.1.2. Germany

            12.3.1.3. France

            12.3.1.4. Italy

            12.3.1.5. Spain

            12.3.1.6. Russia

            12.3.1.7. Rest of Europe 

        12.3.2. By Drug Class

        12.3.3. By Indication

        12.3.4. By Distribution Channel

    12.4.  Market Attractiveness Analysis

    12.5. Key Impact Analysis 

13. Asia Pacific Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        13.3.1.  By Country

            13.3.1.1. China

            13.3.1.2. India

            13.3.1.3. Australia and NZ

            13.3.1.4. ASEAN

            13.3.1.5. Rest of Asia Pacific

        13.3.2. By Drug Class

        13.3.3. By Indication

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Impact Analysis 

14. Middle East and Africa Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        14.3.1.  By Country

            14.3.1.1. GCC Countries

            14.3.1.2. South Africa

            14.3.1.3. Rest of MEA

        14.3.2. By Drug Class

        14.3.3. By Indication

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Impact Analysis 

15. Competition Analysis

    15.1. Competition Dashboard

    15.2. Competition Deep Dive 

        15.2.1. Pfizer Inc.

            15.2.1.1. Company Overview

            15.2.1.2. Segment Overview

            15.2.1.3. ProductOfferings

            15.2.1.4. Financial Analysis

            15.2.1.5. Key Developments

            15.2.1.6. Strategy Overview

        15.2.2. Johnson & Johnson Services, Inc.

            15.2.2.1. Company Overview

            15.2.2.2. Segment Overview

            15.2.2.3. ProductOfferings

            15.2.2.4. Financial Analysis

            15.2.2.5. Key Developments

            15.2.2.6. Strategy Overview

        15.2.3. Bristol-Myers Squibb Company 

            15.2.3.1. Company Overview

            15.2.3.2. Segment Overview

            15.2.3.3. ProductOfferings

            15.2.3.4. Financial Analysis

            15.2.3.5. Key Developments

            15.2.3.6. Strategy Overview

        15.2.4. Sanofi S.A

            15.2.4.1. Company Overview

            15.2.4.2. Segment Overview

            15.2.4.3. ProductOfferings

            15.2.4.4. Financial Analysis

            15.2.4.5. Key Developments

            15.2.4.6. Strategy Overview

        15.2.5. GlaxoSmithKline plc

            15.2.5.1. Company Overview

            15.2.5.2. Segment Overview

            15.2.5.3. ProductOfferings

            15.2.5.4. Financial Analysis

            15.2.5.5. Key Developments

            15.2.5.6. Strategy Overview

        15.2.6. Eli Lilly and Company 

            15.2.6.1. Company Overview

            15.2.6.2. Segment Overview

            15.2.6.3. ProductOfferings

            15.2.6.4. Financial Analysis

            15.2.6.5. Key Developments

            15.2.6.6. Strategy Overview

        15.2.7. Teva Pharmaceutical Industries Ltd

            15.2.7.1. Company Overview

            15.2.7.2. Segment Overview

            15.2.7.3. ProductOfferings

            15.2.7.4. Financial Analysis

            15.2.7.5. Key Developments

            15.2.7.6. Strategy Overview

        15.2.8. Baxter International Inc

            15.2.8.1. Company Overview

            15.2.8.2. Segment Overview

            15.2.8.3. ProductOfferings

            15.2.8.4. Financial Analysis

            15.2.8.5. Key Developments

            15.2.8.6. Strategy Overview

16. Assumptions and Acronyms Used

17. Research Methodology


List of Tables

Table 01: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 02: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 03: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 04: Global Neuropathic Pain Management Size (US$ Mn) 2014-2018 and Forecast 2019-2029 By Region, 

Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 07: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 08: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 11: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 12: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 15: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 16: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 19: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 20: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 23: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 24: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel


List of Figures

Figure 01: Global Neuropathic Pain Management Market Value Share By Drug Class (2019 E)

Figure 02: Global Neuropathic Pain Management Market Value Share By Indication (2019 E)

Figure 03: Global Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)

Figure 04: Global Neuropathic Pain Management Market Value Share By Region (2019 E)

Figure 05: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 06: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 07: Global Neuropathic Pain Management Market Absolute $ Opportunity, 2018 - 2026

Figure 08: Global Neuropathic Pain Management Market Share Analysis (%), By Drug Class, 2018 & 2026

Figure 09: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Drug Class, 2019-2029

Figure 10: Global Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029

Figure 11: Global Neuropathic Pain Management Market Share Analysis (%), By Indication , 2018 & 2026

Figure 12: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Indication , 2019-2029

Figure 13: Global Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029

Figure 14: Global Neuropathic Pain Management Market Share Analysis (%), By Distribution Channel, 2018 & 2026

Figure 15: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Distribution Channel, 2019-2029

Figure 16: Global Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029

Figure 17: Global Neuropathic Pain Management Market Share Analysis (%), By Region, 2018 & 2026

Figure 18: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Region, 2019-2029

Figure 19: Global Neuropathic Pain Management Market Attractiveness Analysis By Region, 2019-2029

Figure 20: North America Neuropathic Pain Management Market Value Share By Drug Class (2019 E)

Figure 21: North America Neuropathic Pain Management Market Value Share By Indication (2019 E)

Figure 22: North America Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)

Figure 23: North America Neuropathic Pain Management Market Value Share By Country (2019 E)

Figure 24: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 25: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 26: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 27: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 28: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 29: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 30: North America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029

Figure 31: North America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029

Figure 32: North America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029

Figure 33: North America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029

Figure 34: Latin America Neuropathic Pain Management Market Value Share By Drug Class (2019 E)

Figure 35: Latin America Neuropathic Pain Management Market Value Share By Indication (2019 E)

Figure 36: Latin America Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)

Figure 37: Latin America Neuropathic Pain Management Market Value Share By Country (2019 E)

Figure 38: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 39: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 40: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 41: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 42: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 43: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 44: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 45: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 46: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 47: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 48: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029

Figure 49: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029

Figure 50: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029

Figure 51: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029

Figure 52: Europe Neuropathic Pain Management Market Value Share By Drug Class (2019 E)

Figure 53: Europe Neuropathic Pain Management Market Value Share By Indication (2019 E)

Figure 54: Europe Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)

Figure 55: Europe Neuropathic Pain Management Market Value Share By Country (2019 E)

Figure 56: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 57: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 58: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 59: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 60: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 61: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 62: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 63: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 64: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 65: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 66: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 67: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 68: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 69: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 70: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 71: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 72: Europe Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029

Figure 73: Europe Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029

Figure 74: Europe Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029

Figure 75: Europe Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029

Figure 76: Asia-Pacific Neuropathic Pain Management Market Value Share By Drug Class (2019 E)

Figure 77: Asia-Pacific Neuropathic Pain Management Market Value Share By Indication (2019 E)

Figure 78: Asia-Pacific Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)

Figure 79: Asia-Pacific Neuropathic Pain Management Market Value Share By Country (2019 E)

Figure 80: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 81: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 82: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 83: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 84: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 85: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 86: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 87: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 88: Australia & New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 89: Australia & New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 90: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 91: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 92: Rest of APAC Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 93: Rest of APAC Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 94: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029

Figure 95: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029

Figure 96: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029

Figure 97: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029

Figure 98: MEA Neuropathic Pain Management Market Value Share By Drug Class (2019 E)

Figure 99: MEA Neuropathic Pain Management Market Value Share By Indication (2019 E)

Figure 100: MEA Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)

Figure 101: MEA Neuropathic Pain Management Market Value Share By Country (2019 E)

Figure 102: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 103: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 104: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 105: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 106: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 107: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 108: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018

Figure 109: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029

Figure 110: MEA Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029

Figure 111: MEA Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029

Figure 112: MEA Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029

Figure 113: MEA Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029

Neuropathic Pain Market - Table of Content

Back To Top